Dr. Giovanni Caforio to Join Stryker’s Board of Directors
Stryker Corporation’s Board of Directors has voted to expand its number of Directors from 10 to 11. Dr. Giovanni Cafori, M.D. has been appointed as the newest Member of the Board, filling the eleventh opening as of December 1, 2020. Giovanni has been with Bristol-Myers Squibb since 2000, and currently serves as Chief Executive Officer and Chairman. During his tenure with Bristol-Myers Squibb, Giovanni oversaw the company’s acquisition of Celgene. He previously held numerous leadership roles with Abbott Laboratories. He is also presently Chairman of the Pharmaceutical Research and Manufacturers of America (PhRMA).
Stryker is one of the world’s leading medical technology companies offering innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. The company, headquartered in Kalamazoo, MI, has approximately 40,000 employees worldwide and generated $14.9 billion in annual global sales in 2019.